CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

STAT News
Original article

STAT+: FDA approves Bristol multiple myeloma treatment, marking debut of novel drug class

FDA Decision
Related Companies

Read the original article

Published by STAT News on August 14, 2026 12:03 PM

Read Original